Dr. Saad Usmani from the Levine Cancer Institute, talks about the multiple myeloma clinical trials and abstracts presented at the annual American Society of Clinical Oncologists (ASCO) meeting in Chicago, IL.


Dr. Saad Usmani is Chief of Plasma Cell Disorders and Director of Clinical Research in Hematologic Malignancies at the Levine Cancer Institute Hematologic Oncology and Blood Disorders and Carolinas HealthCare System.

Previous Post
ASCO 2017: Multiple Myeloma Overview -- Dr. Sagar Lonial
Next Post
ASCO 2017: What's New and Promising in Multiple Myeloma Research

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.